{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:53:53Z","timestamp":1793408033658,"version":"4.5.0"},"reference-count":88,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Glioblastoma (GBM) is the most common primary brain tumor in adults, with a median survival of 15\u201318 months. GBM cells, like all tumors, exhibit a metabolic shift known as the Warburg effect, favoring glycolysis even under normoxic conditions. GLUT1 is a primary glucose transporter in GBM cells and has been found to be overexpressed in these cells. The acidic microenvironment created by glycolysis facilitates immune evasion, therapy resistance, and tumor growth. Overexpression of GLUT1 is driven by hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1), c-Myc, and other pathways which have been correlated with tumor aggressiveness as well as poor prognosis Recent studies have highlighted the therapeutic potential of targeting GLUT1 in GBM. Preclinical research shows that GLUT1 inhibitors, such as WZB117 and BAY-876, effectively impair tumor metabolism, reduce cell viability, and improve survival in vitro and in animal models. GLUT1 expression also serves as a prognostic marker, with elevated levels linked to poor outcomes. This review highlights the importance of GLUT1 in GBM biology as a potential therapeutic target and biomarker.<\/jats:p>","DOI":"10.3390\/brainsci15060585","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:28:42Z","timestamp":1748435322000},"page":"585","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["GLUT1 as a Potential Therapeutic Target in Glioblastoma"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0027-3175","authenticated-orcid":false,"given":"FNU","family":"Ruchika","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2447-4644","authenticated-orcid":false,"given":"Sanika","family":"Suvarnapathaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antolin","family":"Serrano-Farias","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Bettegowda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4798-8231","authenticated-orcid":false,"given":"Jordina","family":"Rincon-Torroella","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"ref_1","first-page":"5","article-title":"Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015\u20132019","volume":"11","author":"Price","year":"2023","journal-title":"Neurooncol. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Guo, J., Xue, Q., Liu, K., Ge, W., Liu, W., Wang, J., Zhang, M., Li, Q.-Y., Cai, D., and Shan, C. (2019). Dimethylaminomicheliolide (DMAMCL) suppresses the proliferation of glioblastoma cells via targeting pyruvate kinase 2 (PKM2) and rewiring aerobic glycolysis. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00993"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Miranda-Gon\u00e7alves, V., Gon\u00e7alves, C.S., Granja, S., de Castro, J.V., Reis, R.M., Costa, B.M., and Baltazar, F. (2021). MCT1 is a new prognostic biomarker and its therapeutic inhibition boosts response to temozolomide in human glioblastoma. Cancers, 13.","DOI":"10.3390\/cancers13143468"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1111\/febs.14201","article-title":"TGF-\u03b21 targets smad, p38 MAPK, and PI 3K\/akt signaling pathways to induce PFKFB 3 gene expression and glycolysis in glioblastoma cells","volume":"284","author":"Fontova","year":"2017","journal-title":"FEBS J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/WNR.0000000000000506","article-title":"Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the warburg effect in glioblastoma","volume":"27","author":"Li","year":"2016","journal-title":"Neuroreport"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sanzey, M., Abdul Rahim, S.A., Oudin, A., Dirkse, A., Kaoma, T., Vallar, L., Herold-Mende, C., Bjerkvig, R., Golebiewska, A., and Niclou, S.P. (2015). Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123544"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"0963689720906777","DOI":"10.1177\/0963689720906777","article-title":"Long noncoding RNA PCED1B-AS1 promotes the warburg effect and tumorigenesis by upregulating HIF-1\u03b1 in glioblastoma","volume":"29","author":"Yao","year":"2020","journal-title":"Cell Transpl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"109718","DOI":"10.1016\/j.cellsig.2020.109718","article-title":"ANXA2P2\/miR-9\/LDHA axis regulates warburg effect and affects glioblastoma proliferation and apoptosis","volume":"74","author":"Du","year":"2020","journal-title":"Cell Signal"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3892\/or.2015.3932","article-title":"mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma","volume":"33","author":"Bache","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2009423","DOI":"10.1080\/23723556.2021.2009423","article-title":"Greasy GLUT1 maintains glioblastoma malignancy","volume":"8","author":"Liu","year":"2021","journal-title":"Mol. Cell Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Guda, M.R., Labak, C.M., Omar, S.I., Asuthkar, S., Airala, S., Tuszynski, J., Tsung, A.J., and Velpula, K.K. (2019). GLUT1 and TUBB4 in glioblastoma could be efficacious targets. Cancers, 11.","DOI":"10.3390\/cancers11091308"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature13306","article-title":"Crystal structure of the human glucose transporter GLUT1","volume":"510","author":"Deng","year":"2014","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1006\/jmcc.1999.0965","article-title":"Myocardial glucose transporter GLUT1: Translocation induced by insulin and ischemia","volume":"31","author":"Egert","year":"1999","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000079489","article-title":"GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer","volume":"66","author":"Rudlowski","year":"2004","journal-title":"Oncology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41391-020-0202-x","article-title":"GLUT1 expression in high-risk prostate cancer: Correlation with 18F-FDG-PET\/CT and clinical outcome","volume":"23","author":"Meziou","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12253-012-9500-5","article-title":"Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers","volume":"18","author":"Krzeslak","year":"2012","journal-title":"Pathol. Oncol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"43356","DOI":"10.18632\/oncotarget.17445","article-title":"The prognostic value of GLUT1 in cancers: A systematic review and meta-analysis","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/MCB.00440-07","article-title":"Hypoxia-inducible factor 1 and dysregulated c-myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1","volume":"27","author":"Kim","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","article-title":"HIF-2\u03b1 promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity","volume":"11","author":"Gordan","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.emboj.7600196","article-title":"HIF-1\u03b1 induces cell cycle arrest by functionally counteracting myc","volume":"23","author":"Koshiji","year":"2004","journal-title":"EMBO J."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zeng, M., Kikuchi, H., Pino, M.S., and Chung, D.C. (2010). Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010966"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2005.11.001","article-title":"Hypoxia confers protection against apoptosis via PI3K\/akt and ERK pathways in lung cancer cells","volume":"242","author":"Lee","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_28","first-page":"461","article-title":"Activation of PI3 kinase\/akt\/HIF-1\u03b1 pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma","volume":"40","author":"Jiao","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_29","first-page":"2101","article-title":"IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of akt to support T-cell survival","volume":"111","author":"Wofford","year":"2008","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MPA.0b013e3181735ccb","article-title":"Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase\/akt pathway in human pancreatic cancer cells","volume":"37","author":"Melstrom","year":"2008","journal-title":"Pancreas"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.oooo.2014.02.007","article-title":"GLUT-1\/TKTL1 coexpression predicts poor outcome in oral squamous cell carcinoma","volume":"117","author":"Grimm","year":"2014","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s13277-012-0518-9","article-title":"The expression of metabolism-related proteins in phyllodes tumors","volume":"34","author":"Kwon","year":"2013","journal-title":"Tumor Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/nly124","article-title":"Expression of GLUT1 in pseudopalisaded and perivascular tumor cells is an independent prognostic factor for patients with glioblastomas","volume":"78","author":"Komaki","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41467-024-46193-z","article-title":"Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression","volume":"15","author":"Khan","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_36","first-page":"315","article-title":"Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K\/akt\/mTOR inhibition in glioblastoma","volume":"14","author":"Venkatesh","year":"2012","journal-title":"Neurooncology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1038\/onc.2013.390","article-title":"Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner","volume":"33","author":"Lim","year":"2014","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/cdd.2008.10","article-title":"Role and regulation of prolyl hydroxylase domain proteins","volume":"15","author":"Fong","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","article-title":"Hypoxia-inducible factor 1 (HIF-1) pathway","volume":"2007","author":"Semenza","year":"2007","journal-title":"Sci. STKE"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1471-4914(02)02317-1","article-title":"HIF-1 and tumor progression: Pathophysiology and therapeutics","volume":"8","author":"Semenza","year":"2002","journal-title":"Trends Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/jnci\/93.17.1337","article-title":"Transcriptional response to hypoxia in human tumors","volume":"93","author":"Lal","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1158\/0008-5472.CAN-03-0846","article-title":"The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression","volume":"64","author":"Armoni","year":"2004","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","article-title":"Transcriptional regulation of the warburg effect in cancer by SIX1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11010-017-3080-3","article-title":"CREB1 regulates glucose transport of glioma cell line U87 by targeting GLUT1","volume":"436","author":"Chen","year":"2017","journal-title":"Mol Cell Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e22229","DOI":"10.1096\/fj.202101736R","article-title":"A positive feedback circuit comprising p21 and HIF-1\u03b1 aggravates hypoxia-induced radioresistance of glioblastoma by promoting Glut1\/LDHA-mediated glycolysis","volume":"36","author":"Jin","year":"2022","journal-title":"FASEB J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41467-021-26180-4","article-title":"DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"13751","DOI":"10.1007\/s13277-016-5219-3","article-title":"miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1","volume":"37","author":"Guo","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/SCS.0000000000001385","article-title":"miR-495 mediates metabolic shift in glioma cells via targeting Glut1","volume":"26","author":"Nie","year":"2015","journal-title":"J. Craniofacial Surg."},{"key":"ref_50","first-page":"1510","article-title":"MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1","volume":"16","author":"Zhang","year":"2014","journal-title":"Neurooncology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12935-020-1149-7","article-title":"MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism","volume":"20","author":"Yin","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1873-3468.13596","article-title":"N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1","volume":"594","author":"Li","year":"2020","journal-title":"FEBS Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"154176","DOI":"10.1016\/j.prp.2022.154176","article-title":"SREBP2\/Rab11s\/GLUT1\/6 network regulates proliferation and migration of glioblastoma","volume":"240","author":"Cheng","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neo.2017.02.009","article-title":"Inhibitors of GLUT\/SLC2A enhance the action of BCNU and temozolomide against high-grade gliomas","volume":"19","author":"Azzalin","year":"2017","journal-title":"Neoplasia"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Atif, F., Yousuf, S., Espinosa-Garcia, C., Sergeeva, E., and Stein, D.G. (2019). Progesterone treatment attenuates glycolytic metabolism and induces senescence in glioblastoma. Sci. Rep., 9.","DOI":"10.1038\/s41598-018-37399-5"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e2310163","DOI":"10.1002\/advs.202310163","article-title":"Metabolism\/immunity dual-regulation thermogels potentiating immunotherapy of glioblastoma through lactate-excretion inhibition and PD-1\/PD-L1 blockade","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18632\/oncotarget.2892","article-title":"Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells","volume":"6","author":"Shibuya","year":"2015","journal-title":"Oncotarget"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acschembio.8b00251","article-title":"Identification of compounds that decrease glioblastoma growth and glucose uptake in vitro","volume":"13","author":"Landis","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mc.20416","article-title":"Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells","volume":"47","author":"Leone","year":"2008","journal-title":"Mol. Carcinog."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jcp.22806","article-title":"Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis","volume":"227","author":"Yang","year":"2012","journal-title":"J. Cell Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jphs.2015.11.001","article-title":"Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo","volume":"129","author":"Wang","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1535370215622583","article-title":"Effects of resveratrol and methoxyamine on the radiosensitivity of iododeoxyuridine in U87MG glioblastoma cell line","volume":"241","author":"Khoei","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"ref_63","first-page":"4619865","article-title":"Resveratrol enhances apoptotic and oxidant effects of paclitaxel through TRPM2 channel activation in DBTRG glioblastoma cells","volume":"2019","author":"Braidy","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_64","first-page":"2050","article-title":"Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-\u03baB-dependent pathway","volume":"27","author":"Huang","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3892\/or.2015.4346","article-title":"Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation","volume":"35","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1002\/jcp.27409","article-title":"Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of wnt signaling pathway","volume":"234","author":"Yang","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.2147\/CMAR.S258584","article-title":"Synergistic effects of resveratrol and temozolomide against glioblastoma cells: Underlying mechanism and therapeutic implications","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1755-5949.2012.00319.x","article-title":"Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway","volume":"18","author":"Yuan","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2011.10.487","article-title":"Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy","volume":"52","author":"Lin","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12935-021-02099-0","article-title":"Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: A mechanistic review","volume":"21","author":"Arabzadeh","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1002\/jcb.26822","article-title":"Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK\/mTOR signaling pathway","volume":"119","author":"Liu","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ygyno.2007.07.065","article-title":"Resveratrol inhibits glucose metabolism in human ovarian cancer cells","volume":"107","author":"Kueck","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1152\/ajpcell.00387.2012","article-title":"Resolution of the direct interaction with and inhibition of the human GLUT1 hexose transporter by resveratrol from its effect on glucose accumulation","volume":"305","author":"Salas","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"735","DOI":"10.17219\/acem\/68979","article-title":"The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells","volume":"27","author":"Kleszcz","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/1940-6207.CAPR-11-0148","article-title":"Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics","volume":"4","author":"Howells","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/CMAR.S4544","article-title":"Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on wnt pathway target gene expression in colonic mucosa and colon cancer","volume":"1","author":"Holcombe","year":"2009","journal-title":"Cancer Manag. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.12154","article-title":"A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma","volume":"160","author":"Popat","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_78","unstructured":"(2024, September 28). Resveratrol in Treating Patients with Colorectal Cancer That Can be Removed by Surgery, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00433576."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jnen\/nlab044","article-title":"Glioblastoma contains topologically distinct proliferative and metabolically defined subpopulations of nestin- and Glut1-expressing cells","volume":"80","author":"Prosniak","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1158\/1535-7163.MCT-15-0247","article-title":"Sensitization of glioblastoma cells to irradiation by modulating the glucose metabolism","volume":"14","author":"Shen","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3171\/2018.12.JNS181798","article-title":"Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity","volume":"132","author":"Lan","year":"2020","journal-title":"J. Neurosurg. JNS"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Li, Y., Ge, Y., Zhao, M., Ding, F., Wang, X., Shi, Z., Ge, X., Wang, X., and Qian, X. (2023). HSP90B1-mediated plasma membrane localization of GLUT1 promotes radioresistance of glioblastomas. J. Biomed. Res., 37.","DOI":"10.7555\/JBR.36.202200234"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1620\/tjem.238.131","article-title":"D-allose inhibits cancer cell growth by reducing GLUT1 expression","volume":"238","author":"Noguchi","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3892\/or.2016.5322","article-title":"Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.7314\/APJCP.2014.15.4.1823","article-title":"HIF-1\u03b1 and GLUT1 gene expression is associated with chemoresistance of acute myeloid leukemia","volume":"15","author":"Song","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood-2005-04-1622","article-title":"The energy-less red blood cell is lost: Erythrocyte enzyme abnormalities of glycolysis","volume":"106","year":"2005","journal-title":"Blood"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00280-007-0480-1","article-title":"Glut-1 as a therapeutic target: Increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies","volume":"61","author":"Evans","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"eabm5214","DOI":"10.1126\/science.abm5214","article-title":"Distinct myeloid-derived suppressor cell populations in human glioblastoma","volume":"387","author":"Jackson","year":"2025","journal-title":"Science"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/6\/585\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:42:35Z","timestamp":1760031755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/6\/585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":88,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["brainsci15060585"],"URL":"https:\/\/doi.org\/10.3390\/brainsci15060585","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}